Update README.md
Browse files
README.md
CHANGED
|
@@ -46,13 +46,7 @@ The JPharmatron-7B is continually pre-trained using 10T tokens from Japanese and
|
|
| 46 |
|
| 47 |
<!-- Address questions around how the model is intended to be used, including the foreseeable users of the model and those affected by the model. -->
|
| 48 |
|
| 49 |
-
This model is
|
| 50 |
-
|
| 51 |
-
### Recommendations
|
| 52 |
-
|
| 53 |
-
<!-- This section is meant to convey recommendations with respect to the bias, risk, and technical limitations. -->
|
| 54 |
-
|
| 55 |
-
Users (both direct and downstream) should be made aware of the risks, biases and limitations of the model. More information needed for further recommendations.
|
| 56 |
|
| 57 |
|
| 58 |
## Evaluation
|
|
|
|
| 46 |
|
| 47 |
<!-- Address questions around how the model is intended to be used, including the foreseeable users of the model and those affected by the model. -->
|
| 48 |
|
| 49 |
+
This model is intended for applications in pharmaceutical paperwork and research. It is not validated for medical use or any other risk-sensitive use.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 50 |
|
| 51 |
|
| 52 |
## Evaluation
|